Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,700.00p
   
  • Change Today:
    -240.00p
  • 52 Week High: 4,100.00
  • 52 Week Low: 3,040.00
  • Currency: UK Pounds
  • Shares Issued: 5.19m
  • Volume: 12,261
  • Market Cap: £192.01m

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
12.58% below the market average12.58% below the market average12.58% below the market average12.58% below the market average12.58% below the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average
1yr Revenue Growth
35.11% above the market average35.11% above the market average35.11% above the market average35.11% above the market average35.11% above the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
50.95% below the market average50.95% below the market average50.95% below the market average50.95% below the market average50.95% below the market average
Sector averageSector averageSector averageSector averageSector average
1yr DPS Growth
60.78% above the market average60.78% above the market average60.78% above the market average60.78% above the market average60.78% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
55.12% above the market average55.12% above the market average55.12% above the market average55.12% above the market average55.12% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average
Price Book Ratio
96.64% below the market average96.64% below the market average96.64% below the market average96.64% below the market average96.64% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
11.76% above the market average11.76% above the market average11.76% above the market average11.76% above the market average11.76% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Chg 3m
65.24% above the market average65.24% above the market average65.24% above the market average65.24% above the market average65.24% above the market average
46.43% above the sector average46.43% above the sector average46.43% above the sector average46.43% above the sector average46.43% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
36.23% above the market average36.23% above the market average36.23% above the market average36.23% above the market average36.23% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Momentum 20
93.84% below the market average93.84% below the market average93.84% below the market average93.84% below the market average93.84% below the market average
96.36% below the sector average96.36% below the sector average96.36% below the sector average96.36% below the sector average96.36% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
68.58% above the market average68.58% above the market average68.58% above the market average68.58% above the market average68.58% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
ROCE
75.64% above the market average75.64% above the market average75.64% above the market average75.64% above the market average75.64% above the market average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
90.11% above the market average90.11% above the market average90.11% above the market average90.11% above the market average90.11% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Forecast EPS
82.19% above the market average82.19% above the market average82.19% above the market average82.19% above the market average82.19% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.36% below the market average35.36% below the market average35.36% below the market average35.36% below the market average35.36% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average
Operating Profit Loss
17.63% above the market average17.63% above the market average17.63% above the market average17.63% above the market average17.63% above the market average
64.29% above the sector average64.29% above the sector average64.29% above the sector average64.29% above the sector average64.29% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
29.61% below the market average29.61% below the market average29.61% below the market average29.61% below the market average29.61% below the market average
7.41% below the sector average7.41% below the sector average7.41% below the sector average7.41% below the sector average7.41% below the sector average
Cash
9.96% below the market average9.96% below the market average9.96% below the market average9.96% below the market average9.96% below the market average
7.41% below the sector average7.41% below the sector average7.41% below the sector average7.41% below the sector average7.41% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
50.09% below the market average50.09% below the market average50.09% below the market average50.09% below the market average50.09% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,700.00p
Change Today -240.00p
% Change -6.09 %
52 Week High 4,100.00
52 Week Low 3,040.00
Volume 12,261
Shares Issued 5.19m
Market Cap £192.01m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.18% below the market average97.18% below the market average97.18% below the market average97.18% below the market average97.18% below the market average
92.86% below the sector average92.86% below the sector average92.86% below the sector average92.86% below the sector average92.86% below the sector average
Price Trend
50.13% above the market average50.13% above the market average50.13% above the market average50.13% above the market average50.13% above the market average
49.09% above the sector average49.09% above the sector average49.09% above the sector average49.09% above the sector average49.09% above the sector average
Income
70.27% below the market average70.27% below the market average70.27% below the market average70.27% below the market average70.27% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Growth
12.93% above the market average12.93% above the market average12.93% above the market average12.93% above the market average12.93% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

Bioventix Dividends

  Latest Previous
  Final Special
Ex-Div 31-Oct-19 31-Oct-19
Paid 15-Nov-19 15-Nov-19
Amount 43.00p 47.00p

Trades for 28-Feb-2020

Time Volume / Share Price
15:36 1,000 @ 3,720.00p
16:35 35 @ 3,700.00p
16:33 250 @ 3,800.00p
16:23 400 @ 3,612.23p
15:41 390 @ 3,800.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page